Hepatocyte growth factor‐modified adipose‐derived mesenchymal stem cells inhibit human hypertrophic scar fibroblast activation

Author:

Zhang Tianli1

Affiliation:

1. Medical College Wuhan University of Science and Technology Wuhan Hubei China

Abstract

AbstractPurposeNucleoside‐modified messenger RNA (modRNA) holds the potential for facilitating genetic enhancement of stem cells. In this study, modRNA encoding hepatocyte growth factor (modHGF) was used to chemically modify adipose‐derived mesenchymal stem cells (ADSCs) and the effect of modified ADSCs on the activation of hypertrophic scar fibroblasts (HSFs) was evaluated.MethodsCCK‐8, wound healing, and transwell assays were utilized to evaluate the viability and migratory potential of modHGF‐engineered ADSCs and their effect on HSF activation. Reverse transcription‐polymerase chain reaction, western blot, and immunofluorescence staining were performed to detect the expression of collagen‐I (Col I), collagen‐III (Col III), alpha‐smooth muscle actin (α‐SMA), matrix metallopeptidase 1 (MMP‐1), and MMP‐3.ResultsTransfection of ADSCs with modHGF (HGF‐ADSC) resulted in enhanced production of HGF. Meanwhile, modHGF modification enhanced the viability and migration of ADSCs. Notably, culture media from HGF‐ADSCs exhibited a more potent inhibitory effect on the proliferation and migration of HSFs. In addition, culture media from HGF‐ADSCs inhibited extracellular matrix synthesis of HSFs, as evidenced by reduced expression levels of Col I, Col III, and α‐SMA, while increasing expression of MMP‐1 and MMP‐3. Conversely, neutralization experiments confirmed that these effects could be effectively alleviated by blocking HGF activity.ConclusionmodHGF modification optimizes the inhibitory effect of ADSCs on HSF activation, which provides a promising alternative for preventing and treating hyperplastic scars.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3